Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers

  • Hazem Ghebeh1, 5,
  • Ghida Majed Sleiman1,
  • Pulicat S Manogaran1,
  • Amer Al-Mazrou1,
  • Eman Barhoush1,
  • Falah H Al-Mohanna2,
  • Asma Tulbah3,
  • Khalid Al-Faqeeh4 and
  • Chaker N Adra1, 6, 7Email author
BMC Cancer201313:289

DOI: 10.1186/1471-2407-13-289

Received: 17 March 2013

Accepted: 4 June 2013

Published: 14 June 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Mar 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
20 Mar 2013 Author responded Author comments - Chaker Adra
Resubmission - Version 3
20 Mar 2013 Submitted Manuscript version 3
17 Apr 2013 Reviewed Reviewer Report - Ming-Feng Hou
26 Apr 2013 Reviewed Reviewer Report - Lao Saal
8 May 2013 Author responded Author comments - Chaker Adra
Resubmission - Version 4
8 May 2013 Submitted Manuscript version 4
16 May 2013 Reviewed Reviewer Report - Ming-Feng Hou
26 May 2013 Reviewed Reviewer Report - Lao Saal
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
4 Jun 2013 Editorially accepted
14 Jun 2013 Article published 10.1186/1471-2407-13-289

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Stem Cell & Tissue Re-engineering Program, King Faisal Specialist Hospital & Research Centre
(2)
Stem Cell & Tissue Re-engineering Program, Departments of Comparative Medicine, King Faisal Specialist Hospital and Research Centre
(3)
Stem Cell & Tissue Re-engineering Program, Departments of Pathology, King Faisal Specialist Hospital and Research Centre
(4)
Stem Cell & Tissue Re-engineering Program, Department of Surgery, King Faisal Specialist Hospital and ResearchCentre
(5)
College of Medicine, Al-Faisal University
(6)
Transplantation Research Center (TRC), Brigham & Women's Hospital and Children’s Hospital Boston, Harvard Medical School
(7)
Stem Cell & Tissue Re-engineering Program, Research Centre, King Faisal Specialist Hospital and Research Centre

Advertisement